CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report)’s share price fell 5.3% during trading on Monday . The company traded as low as C$27.00 and last traded at C$27.00. 52,208 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Stock Down 5.3 %
The company has a fifty day simple moving average of C$27.00.
CanniMed Therapeutics Company Profile
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Further Reading
- Five stocks we like better than CanniMed Therapeutics
- What Is WallStreetBets and What Stocks Are They Targeting?
- The Average 401k Balance by Age Explained
- Do ETFs Pay Dividends? What You Need to Know
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How to Calculate Inflation Rate
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.